2017
DOI: 10.1016/j.wneu.2016.11.138
|View full text |Cite
|
Sign up to set email alerts
|

Traumatic Anterior Cerebral Artery Pseudoaneurysmal Epistaxis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…The advantage of selective pseudoaneurysm embolization is the preservation of the parent artery (Figure 2). However, pseudoaneurysm recurrence is still a major issue for patients treated with simple coiling (7,9,11,14,16,26,30,53,60,63). Due to coil impaction into the thrombus (14), flow pulsatility may force into the interstices of the coil mass and lead to recurrent bleeding (27).…”
Section: Endovascular Embolizationmentioning
confidence: 99%
“…The advantage of selective pseudoaneurysm embolization is the preservation of the parent artery (Figure 2). However, pseudoaneurysm recurrence is still a major issue for patients treated with simple coiling (7,9,11,14,16,26,30,53,60,63). Due to coil impaction into the thrombus (14), flow pulsatility may force into the interstices of the coil mass and lead to recurrent bleeding (27).…”
Section: Endovascular Embolizationmentioning
confidence: 99%
“…34 The choice of procedure in the setting of catastrophic hemorrhage due to underlying anatomic pathology is driven by what is most likely to be rapidly successful. [15][16][17][18][19] Systemic (intravenous) treatment with the anti-vascular endothelial growth factor monoclonal antibody bevacizumab has been shown to be effective in decreasing the frequency of hemorrhagic complications of HHT. 35,36 However, it has been challenging to demonstrate any significant decrease in frequency and severity of epistaxis.…”
mentioning
confidence: 99%